Live
PfizerShould you buy pharma stocks? Dr Reddy's, Pfizer - Target prices after Q4 results - Business TodayClinical OMICsASGCT 2026: Timothy Yu Wins Jerry Mendell Award For N-of-1 TherapiesClinical OMICsTargeted Ultrasound Could Offer Alternative to Chronic Pain MedicationThermo FisherNuvation Bio partners with Thermo Fisher for US drug manufacturing - Investing.comClinical OMICsTNBC Ecotypes Reveal Molecular Signatures Tied to Chemotherapy ResponseClinical OMICsCSF Platform Enables Near Real-Time Monitoring of Multiple BiomarkersEndpoints NewsAfter an apparent cure, a gene editing company struggles to repeat the magicEndpoints NewsTakeda to target 4,500 jobs as incoming CEO continues restructuringClinical OMICsPersonalized DNA Vaccine Shows Immune Activation and Survival Signals in Glioblastoma TrialIlluminaAs Trump arrives in China, Big Pharma CEOs are notably absent - Fierce PharmaClinical OMICsAberrant Splicing Patterns Could Predict Therapy Response in mRCCClinical OMICsRate of New Late-Stage Breast Cancers Increases
Thermo Fisher Mar 29, 2026

Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Body unavailable. Use the original source.